Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BASE Trial: Valsartan vs Atenolol in Small Abdominal Aortic Aneurysm
NCT01904981Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Jan 2014
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of valsartan in abdominal aortic aneurysm (AAA) (2 arms), sponsored by Yonsei University. Primary endpoint: Annual aneurysm growth of abdominal aortic aneurysm at 12 months. Started Jan 2014; status: completed.
02
Drugs
valsartan
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT01904981.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01904981.